Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.720
-0.050 (-1.81%)
Aug 14, 2025, 9:25 AM - Market open

BDTX Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Selling, General & Admin
17.3124.5227.1128.3930.0421.36
Upgrade
Research & Development
45.0451.3159.3564.4496.8348.21
Upgrade
Operating Expenses
62.3575.8486.4692.83126.8769.57
Upgrade
Operating Income
7.65-75.84-86.46-92.83-126.87-69.57
Upgrade
Interest Expense
------0
Upgrade
Interest & Investment Income
2.792.181.922.033.464.04
Upgrade
Earnings From Equity Investments
----2.25--
Upgrade
Currency Exchange Gain (Loss)
-----00
Upgrade
Other Non Operating Income (Expenses)
4.363.140.920.18--
Upgrade
EBT Excluding Unusual Items
14.8-70.51-83.62-92.87-123.41-65.53
Upgrade
Merger & Restructuring Charges
-2.95-2.95----
Upgrade
Gain (Loss) on Sale of Investments
2.583.781.17-0.54-2.19-1.73
Upgrade
Gain (Loss) on Sale of Assets
---2.23--
Upgrade
Pretax Income
14.44-69.68-82.44-91.17-125.6-67.25
Upgrade
Net Income
14.44-69.68-82.44-91.17-125.6-67.25
Upgrade
Net Income to Common
14.44-69.68-82.44-91.17-125.6-67.25
Upgrade
Shares Outstanding (Basic)
575544363633
Upgrade
Shares Outstanding (Diluted)
575544363633
Upgrade
Shares Change (YoY)
8.73%25.19%21.00%0.38%9.97%1485.31%
Upgrade
EPS (Basic)
0.25-1.27-1.88-2.51-3.47-2.04
Upgrade
EPS (Diluted)
0.25-1.27-1.88-2.51-3.47-2.05
Upgrade
Free Cash Flow
17.87-62.3-66.75-85.27-102.86-52.29
Upgrade
Free Cash Flow Per Share
0.31-1.13-1.52-2.35-2.84-1.59
Upgrade
EBITDA
7.99-75.49-86.02-92.32-126.67-69.52
Upgrade
D&A For EBITDA
0.340.340.440.510.210.05
Upgrade
EBIT
7.65-75.84-86.46-92.83-126.87-69.57
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q